U.S. Patent Office permits finalization of sphingotec’s penKid patent

sphingotec just received a Notice of Allowance from the United States Patent and Trademark Office confirming that sphingotec’s method of measuring Proenkephalin (penKid) for the Diagnosis and Monitoring of Kidney (Dys)function qualifies for a patent in the United States. This now enables sphingotec to finalize its U.S. penKid patent.